Trial data show that patients who continue therapy tend to maintain their loss, while those who stop tend to regain a substantial portion which is why it is framed as a maintenance therapy, not a temporary course
The same GLP-1 receptor agonist that Ozempic selectively binds to and activates the GLP-1 receptor, the target for native GLP-1
These data indicate that PAPR-1 induces LXR poly(ADP-ribosyl)ation, therefore inhibiting LXR-induced ABCA1 expression in INS-1 cells
Recovery from a mini tummy tuck is longer and involves a larger incision but is less invasive than a full tummy tuck
Advances in nanotechnology liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), niosomes, and polymer-based nanoparticles improve solubility, dermal penetration, and sustained release of polyphenols, enhancing their therapeutic efficacy in PsO models